Following up the inspection carried on by the Italian Agency for Pharma (AIFA) from 30/05/16 to 01/06/16, on September 22nd 2016 MIAT got GMP certificate obtaining therefore the authorization to produce in contract manufacturing and also import pharmaceutical active ingredients.
